Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07199465 · ClinicalTrials.gov registry record · Phase 1
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
A Phase 1 study of Cytomegalovirus Prophylaxis, sponsored by Merck Sharp & Dohme.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 10
- Study locations
NCT07199465 is a Phase 1 study of Cytomegalovirus Prophylaxis that is actively recruiting participants, run by Merck Sharp & Dohme. The registered enrollment target is 40 participants. The trial reports 10 study locations across 7 states.
The verdict
NCT07199465, a Phase 1 study of Cytomegalovirus Prophylaxis, is actively recruiting participants, sponsored by Merck Sharp & Dohme.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 10
- Study locations
Study Summary
Researchers are looking for a way to prevent cytomegalovirus (CMV) in children and adolescents who receive a kidney transplant (KT) and weigh less than 40 kilograms (88.2 pounds). The goals of the study are to: * Learn what happens to letermovir in the body over time * Learn about the safety of letermovir and if participants tolerate it
Conditions Studied
Interventions
- DRUG Letermovir
Study Locations (10)
California
- UCLA Clinical & Translational Research Center (CTRC) ( Site 0006) - Los Angeles
- Lucile Packard Children's Hospital ( Site 0001) - Palo Alto
- University of California Davis Health ( Site 0023) - Sacramento
- UCSF Medical Center at Mission Bay ( Site 0017) - San Francisco
Colorado
- Children's Hospital Colorado ( Site 0013) - Aurora
Michigan
- University of Michigan ( Site 0014) - Ann Arbor
Minnesota
- Mayo Clinic - Rochester ( Site 0015) - Rochester
New York
- Morgan Stanley Children's Hospital ( Site 0018) - New York
North Carolina
- Duke University Medical Center ( Site 0008) - Durham
Ohio
- Cincinnati Children's Hospital Medical Center ( Site 0002) - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-04-24 |
| Est. Completion | 2028-05-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07199465
The ClinicalTrials.gov registry entry for NCT07199465 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merck Sharp & Dohme, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cytomegalovirus Prophylaxis appearing as the primary indexed condition, and to 1 intervention - of which Letermovir is the first listed.
NCT07199465 reports 10 study locations spanning 7 distinct geographic areas - top geographies include California, Colorado, Michigan.
Frequently Asked Questions
What is clinical trial NCT07199465 about?
NCT07199465 is a clinical study titled "A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)". Researchers are looking for a way to prevent cytomegalovirus (CMV) in children and adolescents who receive a kidney transplant (KT) and weigh less than 40 kilograms (88.2 pounds). The goals of the study are to: * Learn what happens to letermovir in the body over time * Learn about the safety of let...
What is the current status of trial NCT07199465?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2026-04-24. Estimated completion is 2028-05-19.
What conditions does trial NCT07199465 study?
This clinical trial studies the following conditions: Cytomegalovirus Prophylaxis.
What interventions are being tested in trial NCT07199465?
The interventions under investigation include: Letermovir (DRUG).
Who is sponsoring clinical trial NCT07199465?
This trial is sponsored by Merck Sharp & Dohme, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07199465 being conducted?
This trial has 10 study locations across California, Colorado, Michigan, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.